The LiverWELL Podcast with Dr Tram Tran: Some good news about diagnosing NASH

May 3, 2022

This week’s LiverWELL podcast features Dr Tram Tran, who is the Chief Medical Officer for Glympse Bio, and a renowned liver and viral hepatitis specialist with over 20 years of academic and industry experience at Gilead, Cedars-Sinai, and UCLA Geffen School of Medicine.

The scale and burden of liver health issues and liver disease in the US reflects that of Australia, with NASH or non-alcoholic fatty liver disease affecting one in four people, and this figure is growing alarmingly.

However, there is some good news on the horizon. Glympse Bio claim they are perfecting a first-of-its-kind blood test to diagnose and monitor non-alcoholic steatohepatitis (otherwise known as NASH).  Glympse has presented data demonstrating that their technology is 97% accurate in predicting or diagnosing NASH in patients by measuring protease activity in blood samples.

This has the potential to be groundbreaking in the field of hepatology. Currently diagnosing NASH is either painful and invasive, or dangerously vague (depending on the medical approach taken), and only 80-90% accurate. This test would provide both an accurate diagnosis and a baseline for monitoring the progression of the disease in patients.

Reducing the burden of liver disease on economies and health systems is essential. We hope to hear more about this diagnostic platform in the future and one day see it in use.

Listen to the podcast with Dr. Tran.

LiverWELL · Dr. Tram Tran gives us an inside look into new developments regarding the diagnosis of NASH

More on the Glympse Bio data


We are here to answer your queries and support you. Call or chat with us online.
LiverWELL acknowledges the support of the Victorian Government.
We welcome people from all cultures, nationalities and religions. Being inclusive and providing equitable services is our commitment.

ABN 48 656 812 701

We acknowledge the traditional owners of the lands where we work - the lands of the Woi-Wurrung Wurundjeri people of the Kulin Nations. We express our gratitude to them for their continued care and curation of these lands and waters. We pay our respects to Elders past and present.

LiverWELL observes and honours the Kulin Nation's intrinsic connection to land, sky and water, and the creator Bunjil. LiverWELL is committed to being led and informed by Aboriginal and Torres Strait Islanders on bridging health outcomes for communities and improving liver health.